Pinealon
Glu-Asp-Arg (EDR)
Pinealon is a synthetic tripeptide studied in cellular oxidative-stress models.
Peptipedia explains research and prescribing information. It does not replace medical advice and is not an invitation to use a substance.
Research areas
Evidence matrix
- Molecular identity
- Confirmed
The cited primary study defines Pinealon as the synthetic tripeptide Glu-Asp-Arg (EDR). This assignment does not confirm the identity of an untested commercial product.
- Human research
- None
- Replication
- Single research group
- Clinical endpoints
- No clinical endpoints
- Safety
- Not adequately studied
- Approval
- No documented approval
The dimensions are presented separately and are not combined into an overall score.
What the source shows
Researchers measured cellular effects in several cell models, not memory improvement or neurological function in a clinical trial.
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processesLaboratory study2011
Khavinson V et al.
Accessed:
Research gaps
- ·Cell viability is not equivalent to neurological benefit in humans; independent replication and human data are absent.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
Mechanism
Experiments describe changes in reactive oxygen species, ERK activation and cell-cycle processes; direct genomic interaction remains an experimental interpretation.
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processesLaboratory study2011
Khavinson V et al.
Accessed:
Study protocols
No sufficiently supported, exactly citable study protocols are available.
Calculator
Arithmetic based only on your entries. Not a dose or use recommendation.
Reported adverse effects
- ·Evidence is insufficient; absence of data is not evidence of safety. Human exposure, long-term toxicology, contraindications and interactions have not been adequately studied.
Contraindications and warnings
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Interactions
No reviewed information on this point has been recorded here yet. This does not mean there are no risks or contraindications.
Research gaps
- ·Cell viability is not equivalent to neurological benefit in humans; independent replication and human data are absent.
- ·Short profile: not a complete benefit–risk assessment. Unlisted contraindications and interactions are not adequately established in this profile; missing information does not establish safety.
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processesLaboratory study2011
Khavinson V et al.
Accessed:
Sources
Sources checked: · Version 3
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processesLaboratory study2011
Khavinson V et al.
Accessed: